Gilead Sciences GILD
NASDAQ GILD
$151.17 +4.07 (+2.77%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

Gilead Sciences (GILD) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 159.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.02 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 2.04 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 2.35 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Bn
Mar 31, 2026 2.52 Bn
Dec 31, 2025 340.00 Mn
Sep 30, 2025 219.00 Mn
Jun 30, 2025 295.00 Mn
Mar 31, 2024 2.27 Bn
Dec 31, 2023 349.00 Mn
Sep 30, 2023 266.00 Mn
Jun 30, 2023 395.00 Mn
Mar 31, 2023 324.00 Mn
Dec 31, 2022 358.00 Mn
Sep 30, 2022 277.00 Mn
Jun 30, 2022 449.00 Mn
Mar 31, 2022 506.00 Mn
Dec 31, 2021 372.00 Mn
Sep 30, 2021 558.00 Mn
Jun 30, 2021 631.00 Mn
Mar 31, 2021 619.00 Mn
Dec 31, 2020 10.87 Bn
Sep 30, 2020 1.94 Bn
API Access

Gilead Sciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GILD&period=max&api_key=YOUR_API_KEY